Atara Biotherapeutics (ATRA) PT Raised to $41 at Mizuho Securities
Tweet Send to a Friend
Mizuho Securities analyst Salim Syed raised the price target on Atara Biotherapeutics (NASDAQ: ATRA) to $41.00 (from $38.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
